rslv-132
Showing 1 - 3 of 3
Post-acute Corona Virus 19 (COVID-19) (Long COVID) Trial in United States (RSLV-132, Sodium Chloride 0.9%)
Active, not recruiting
- Post-acute Corona Virus 19 (COVID-19) (Long COVID)
- RSLV-132
- Sodium Chloride 0.9%
-
Mobile, Alabama
- +4 more
Nov 4, 2022
Sjogren's Syndrome Trial in Birmingham, Newcastle upon Tyne (RSLV-132, Placebo)
Completed
- Sjogren's Syndrome
- RSLV-132
- Placebo
-
Birmingham, Edgbaston, United Kingdom
- +1 more
Mar 9, 2021
Systemic Lupus Erythematosus Trial in United States (RSLV-132, Placebo)
Completed
- Systemic Lupus Erythematosus
- RSLV-132
- Placebo
-
El Cajon, California
- +15 more
Mar 9, 2021